3rd Quarter - Report
CROSSROADS STRATEGIES, LLC for INTELLIA THERAPEUTICS
Client
Income
$30,000
Expenses
—
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Education and advocacy related to genome editing technology; COVID-19 therapies; drug pricing; FY2022 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act (H.R.4502); S.909, The Prescription Drug Price Relief Act; S.908, The Medicare Drug Price Negotiation Act; S.920, The Affordable and Safe Prescription Drug Importation Act; H.R.3, Elijah E. Cummings Lower Drug Costs Now Act.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JASON GLEASON | — |
| BRITTANY JOHNSON HERNANDEZ | — |
| MATHEW LAPINSKI | — |
| JASON BENJAMIN VAN PELT | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.